Publications in collaboration with researchers from Icahn School of Medicine at Mount Sinai (26)

2022

  1. Talquetamab, a T-Cell-Redirecting GPRC5D Bispecific Antibody for Multiple Myeloma

    The New England journal of medicine, Vol. 387, Núm. 24, pp. 2232-2244

  2. Teclistamab in Relapsed or Refractory Multiple Myeloma

    New England Journal of Medicine, Vol. 387, Núm. 6, pp. 495-505